Stability Testing for FDA Approved KSHNO14 (Pyridostigmine Bromide Extend – Release Tablets)
W911SR-26-S-ASPC
This is a market research notice seeking potential sources capable of supporting FDA-compliant, long-term stability testing for a specific drug product. The required testing involves a five-year study at controlled room temperature and a ten-year study under refrigerated conditions. The services would support an existing, ongoing stability study, requiring continuity with that effort. The notice explicitly states it is not a solicitation for proposals and no award will be made from it. No specific budget, performance location, or submission timelines for a future bid are provided.